Epigeneres

Early cancer detection through epigenetic biomarker science

Mumbai, India · Founded 2008 · $6.0M raised

Headquarters
Mumbai
Employees
11–50
Founded
2008
Business Model
B2B
Total Funding
$6.0M
Last Round
$6.0M Series BDec 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Epigeneres Biotech Private Limited is an Indian biotechnology company founded in 2008, focused on early cancer detection and stem cell research. The company co-developed a proprietary epigenetic cancer detection technology in collaboration with Singapore-based Tzar Labs, which uses HrC (Hematopoietic Regenerative Cells) biomarkers for non-invasive early cancer screening. Epigeneres holds a licensing agreement with Tzar Labs for the Indian territory. The company's diagnostic business has since been rebranded as Tzar Labs India, while Epigeneres continues research into pluripotent stem cells and maintains scientific collaborations with academic institutions.

Summary

Epigeneres is a Biotech company based in Mumbai, India, founded in 2008. It has raised $6.0M in total across 1 round, most recently a $6.0M Series B round in Dec 2021. Investors include Kotak Investment Advisors.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2021
$6.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epigeneres on Indexed.vc
<a href="https://indexed.vc/companies/epigeneres"><img src="https://indexed.vc/api/badge/company/epigeneres" alt="Epigeneres on Indexed.vc" width="260" height="76" /></a>